Meril Life Sciences
Meril Life Sciences was founded in 2006 as an investment project of the independent Indian multi-profile holding named Bilakhia, known for its partnership with such world giants as Hubergroup and Bayer CropScience.
To date, Meril Life Sciences is a high-tech medical company that improves and develops new, clinically relevant, high-quality devices designed to alleviate human suffering and improve quality of life. The company's portfolio includes devices for invasive procedures, endo-surgery, orthopedics, as well as devices for laboratory diagnostics.
The pride of the company is a state-of-the-art production complex with a total area of more than 300 thousand square feet with production facilities certified to ISO 13485 and GMP standards. A unique and fully integrated production system ensures impeccable product quality and complete control over product testing processes, eliminating any manufacturing errors.
Meril Life Sciences has about 1,400 employees on its staff, which together form a strong and experienced team consisting of designers, engineers, chemists, microbiologists, research and development scientists, clinical experts, lawyers, marketers, and sales managers. All team members work daily to save lives, providing revolutionary solutions for diagnosis, prevention and treatment.
A major role in the activity of Meril Life Sciences is also given to practical training of physicians, which allows to bridge the gap between technology and actual sales of products.
Currently, the company has representative offices in India, Germany, Turkey, USA, China and Brazil, as well as an extensive distribution network in more than 102 countries.
Daksmed Group of Companies presents products for invasive procedures developed by Meril Life Sciences: Coronary angioplasty, Peripheral angioplasty